Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVianet Grp Regulatory News (VNET)

Share Price Information for Vianet Grp (VNET)

Share Price is delayed by 15 minutes
Get Live Data
69.50    0.50 (0.72%)
Bid:
67.00
Ask:
72.00
Spread: 5.00 (7.463%)
Market Cap: £19.76m
VNET Live PriceLast checked at - London Stock Exchange

Intraday Vianet Grp Share Chart

Form 8 (OPD) (Brulines Group PLC)

29 Apr 2010 12:06

RNS Number : 0363L
Brulines Group PLC
29 April 2010
 



FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the party to the offer making the disclosure:

Brulines Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each party to the offer

Brulines Group plc

(d) Is the party to the offer making the disclosure the offeror or the offeree?

OFFEROR

(e) Date position held:

22 April 2010

(f) Has the party previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

YES

If YES, specify which:

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

In no. 2 you need to list any shares that he company holds in itself

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

216,000

0.77

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(c) Irrevocable commitments and letters of intent

 

Details of any irrevocable commitments or letters of intent procured by the party to the offer making the disclosure or any person acting in concert with it (see Note 3 on Rule 2.11 of the Code):

 

 

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe of any person acting in concert with the party to the offer making the disclosure:

 

Director Holding Total Options

James Dickson 3,711,168 (13.24%) 175,000

Mark Foster 75,000 (0.27%) 315,000

Duncan Noble 347,468 (1.24%) 285,000

James Newman 30,000 (0.11%) 66,000

Stewart Gilliland 26,000 (0.09%) 54,000

Stewart Darling - 200,000

 

Directors holdings and options need to go here.

 

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3 for each additional class of relevant security.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

None

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

23 April 2010

Contact name:

Mark H Foster

Telephone number:

01642 358800

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEEUKARRROASUAR
Date   Source Headline
3rd Dec 202412:02 pmRNSShare Buyback Prorgramme
3rd Dec 20247:00 amRNSInterim Results
4th Nov 20244:10 pmRNSHolding(s) in Company
4th Nov 20249:05 amRNSInvestor Presentation via Investor Meet Company.
4th Nov 20247:00 amRNSTrading Update and Notice of Results
5th Sep 202411:30 amRNSExercise of Options
18th Jul 202412:45 pmRNSResult of AGM
18th Jul 20247:00 amRNSAGM Statement
20th Jun 202412:00 pmRNSAnnual Financial Report
11th Jun 20247:00 amRNSFinal Results
29th Apr 20247:00 amRNSInvestor Presentation via Investor Meet Company
25th Apr 20247:01 amRNSTrading Update and Notice of Results
25th Apr 20247:00 amRNSContract Win
4th Apr 202410:30 amRNSExercise of options
14th Mar 20242:00 pmRNSExercise of Options
24th Jan 20244:38 pmRNSDirector/PDMR Shareholding
23rd Jan 20244:15 pmRNSDirector/PDMR Shareholding
18th Jan 20246:20 pmRNSShare Buyback and Total Voting Rights
10th Jan 20246:15 pmRNSShare Buyback and Total Voting Rights
9th Jan 20247:00 amRNSShare Buyback and Total Voting Rights
8th Jan 20247:00 amRNSShare Buyback and Total Voting Rights
2nd Jan 20247:00 amRNSShare Buyback and Total Voting Rights
22nd Dec 202312:45 pmRNSShare Buyback and Total Voting Rights
18th Dec 202310:00 amRNSShare Buyback and Total Voting Rights
15th Dec 202312:00 pmRNSHolding(s) in Company
14th Dec 20239:15 amRNSShare Buyback and Total Voting Rights
12th Dec 20237:00 amRNSHalf-year Report
4th Dec 20239:30 amRNSInvestor Presentation via Investor Meet Company
13th Nov 20237:00 amRNSDirector/PDMR Shareholding
9th Nov 20231:10 pmRNSFurther re Share Buyback
7th Nov 20232:28 pmRNSShare Buyback Prorgramme
6th Nov 202310:17 amRNSDirector/PDMR Shareholding
1st Nov 20237:00 amRNSTrading Update and Notice of Results
9th Oct 20232:48 pmRNSChange of Adviser
13th Sep 202311:46 amRNSAnnual Financial Report
5th Sep 202312:20 pmRNSResult of AGM
5th Sep 20237:00 amRNSAGM Statement
14th Jun 20231:47 pmRNSExercise of Options
13th Jun 202311:12 amRNSReplacement RNS: Final Results
13th Jun 20237:00 amRNSFinal Results
5th Jun 20231:49 pmRNSNotice of Results and Investor Presentation
5th Jun 20237:00 amRNSHMRC R&D Tax Refund
15th May 20237:00 amRNSStrategic acquisition of trade and assets
2nd May 20237:00 amRNSTrading Update and Notice of Results
21st Mar 20237:00 amRNSVianet partners with Vendekin Technologies
20th Feb 20232:38 pmRNSGrant of Options
1st Feb 202312:00 pmRNSHolding(s) in Company
6th Dec 20227:00 amRNSHalf-year Report
25th Nov 20227:00 amRNSUnattended contactless payment solution launched
18th Nov 20227:00 amRNSInvestors Meet Company : Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.